Skip to search formSkip to main contentSkip to account menu

LBM415

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Peptide deformylase (PDF) inhibitors represent a potential new class of antibiotics targeting a large number of bacterial species… 
2009
2009
ABSTRACT LBM415 is an antibacterial agent belonging to the peptide deformylase inhibitor class of compounds. It has previously… 
2007
2007
ABSTRACT Previous genetic analysis of Haemophilus influenzae revealed two mechanisms associated with decreased susceptibility to… 
2006
2006
ABSTRACT When tested against 254 Haemophilus influenzae strains, LBM415, a peptide deformylase inhibitor, gave MIC50 and MIC90… 
2006
2006
ABSTRACT LBM415 is a peptide deformylase inhibitor active against gram-positive bacterial species and some gram-negative species… 
Highly Cited
2005
Highly Cited
2005
ABSTRACT LBM415 (NVP PDF-713) is the first member of the peptide deformylase (PDF) inhibitor class being developed for clinical… 
2005
2005
Fluconazole MICs obtained with the modified BMD tests and Etest read at 24 and 48 h were compared with the reference BMD MICs… 
2004
2004
ABSTRACT The MICs of LBM415, a new peptide diformylase inhibitor, were ≤0.06 to 4.0 μg/ml for 258 isolates of Staphylococcus… 
2004
2004
ABSTRACT The MICs of LBM415, a new peptide diformylase inhibitor, were evaluated and ranged from 0.03 to 4.0 μg/ml for 300…